meddevicedb.com FDA Device Reference

CORE 300 Digital Stethoscope

K261694 Class II Traditional
Decision Date
2026-07-23
Sponsor / Applicant
Eko Health, Inc.

Technical Specification

510(k) Submission ID K261694
Product Code DQD
Medical Specialty / Panel Cardiovascular
Regulation Citation 21 CFR 870.1875
Decision Date 2026-07-23
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

CORE 300 Digital Stethoscope received FDA 510(k) clearance under submission number K261694, sponsored by Eko Health, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2026-07-23.

Classification & Regulation

This clearance is catalogued under FDA product code DQD and 21 CFR 870.1875, within the Cardiovascular review panel as a Class II device.